Two long-recommended methods seem effective and bring no psychological harm, study finds
Researchers suspect low levels of spexin might play contributing role
Consuming limited amount of low-fiber food day before didn't disrupt procedure, study finds
Study raises provocative questions, expert says
Eased symptoms, healed colons in 1 in 4 patients
Monsanto Co , the world's largest seed company, will reject Bayer AG's $62 billion acquisition bid and seek a higher price, two people familiar with the matter said on Tuesday. Monsanto can see the logic of combining with the German drugs and crop chemicals group, and believes a deal could get the necessary antitrust and other regulatory approvals, the people said, leaving the door open for further negotiations. Bayer will now have to decide whether to raise its bid, even as the company faces criticism from some shareholders that its $122-per-share offer is already too high.
By Kate Kelland LONDON (Reuters) - People with diabetes should be offered gastric surgery as a standard treatment option which could help control it for years without medication, the world's leading diabetes groups said. A joint statement from a 45-strong group said on Tuesday that bariatric, or metabolic, surgery could have a significant benefit for hundreds of thousands of patients worldwide, which they said represented one of the biggest shifts in diabetes treatment guidelines since the advent of insulin. The new guidelines say surgery to reduce the stomach and induce weight loss should be recommended to treat all diabetes patients whose body mass index (BMI) is 40 or over, regardless of their blood glucose control, as well as those with a BMI of 30 and over whose blood sugar levels are not being controlled by lifestyle changes or medication.
By Caroline Humer NEW YORK (Reuters) - Anthem Inc Chief Executive Officer Joseph Swedish said on Tuesday the health insurer was pushing for approval from antitrust regulators reviewing its $51 billion acquisition of Cigna Corp and expects to hear a decision in July. Anthem's bid for Cigna followed closely after Aetna Inc's proposed $34 billion purchase of Humana Inc last July. Swedish said antitrust regulators have asked many questions about how it and Cigna manage healthcare benefits for large employers, but that the overall review was moving forward as expected.